Literature DB >> 21051618

Cancer. Awakening immunity.

Hans Schreiber1, Donald A Rowley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051618     DOI: 10.1126/science.1198345

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  16 in total

1.  Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.

Authors:  Minfeng Chen; Xueping Lei; Changzheng Shi; Maohua Huang; Xiaobo Li; Baojian Wu; Zhengqiu Li; Weili Han; Bin Du; Jianyang Hu; Qiulin Nie; Weiqian Mai; Nan Ma; Nanhui Xu; Xinyi Zhang; Chunlin Fan; Aihua Hong; Minghan Xia; Liangping Luo; Ande Ma; Hongsheng Li; Qiang Yu; Heru Chen; Dongmei Zhang; Wencai Ye
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

2.  Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.

Authors:  Sandra J Yokota; John G Facciponte; Raymond J Kelleher; Leonard D Shultz; Jenni L Loyall; Robert R Parsons; Kunle Odunsi; John G Frelinger; Edith M Lord; Scott A Gerber; Sathy V Balu-Iyer; Richard B Bankert
Journal:  Cancer Immun       Date:  2013-05-31

3.  Inter-cellular signaling network reveals a mechanistic transition in tumor microenvironment.

Authors:  Yu Wu; Lana X Garmire; Rong Fan
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

4.  Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.

Authors:  Matthias T Stephan; Darrell J Irvine
Journal:  Nano Today       Date:  2011-06-01       Impact factor: 20.722

5.  Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction.

Authors:  Christopher J Scarlett; Emily K Colvin; Mark Pinese; David K Chang; Adrienne L Morey; Elizabeth A Musgrove; Marina Pajic; Minoti Apte; Susan M Henshall; Robert L Sutherland; James G Kench; Andrew V Biankin
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

6.  In silico experimentation of glioma microenvironment development and anti-tumor therapy.

Authors:  Yu Wu; Yao Lu; Weiqiang Chen; Jianping Fu; Rong Fan
Journal:  PLoS Comput Biol       Date:  2012-02-02       Impact factor: 4.475

Review 7.  Modulation of tumor tolerance in primary central nervous system malignancies.

Authors:  Theodore S Johnson; David H Munn; Bernard L Maria
Journal:  Clin Dev Immunol       Date:  2012-01-24

8.  A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts.

Authors:  Meihua Chen; Rong Xiang; Yuan Wen; Guangchao Xu; Chunting Wang; Shuntao Luo; Tao Yin; Xiawei Wei; Bin Shao; Ning Liu; Fuchun Guo; Meng Li; Shuang Zhang; Minmin Li; Kexing Ren; Yongsheng Wang; Yuquan Wei
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

9.  Contribution of bone marrow derived cells to the pancreatic tumor microenvironment.

Authors:  Christopher J Scarlett
Journal:  Front Physiol       Date:  2013-03-26       Impact factor: 4.566

10.  Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report.

Authors:  Rui Liao; Zhuo-Wei Tang; De-Wei Li; Shi-Qiao Luo; Ping Huang; Cheng-You Du
Journal:  World J Surg Oncol       Date:  2015-09-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.